DGAP-Adhoc: Eckert & Ziegler: Disappointing Radiation Therapy business in Eastern Europe threatens to undermine consolidated profit forecast for 2014

| Source: EQS Group AG EQS Group AG 

Eckert & Ziegler Strahlen- und Medizintechnik AG  / Key word(s): Profit Warning

05.01.2015 17:40

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Berlin, January 5, 2015 - The Radiation Therapy segment of Eckert & Ziegler
Strahlen- und Medizintechnik AG was unable to match the sales levels of
previous years in the last quarter of 2014 due to the economic and
political crisis in Eastern Europe. Compared to the period from 2011 to
2013, annual sales in the former CIS countries were down by half to almost
EUR 4 million in 2014, which means total sales for the segment were merely
on par with the previous year's figure of EUR 28 million. In view of the
low capacity utilization in production and a business development in the
United States which proved more challenging than expected overall, the
Radiation Therapy segment posted a loss on earnings before interest and
taxes (EBIT) of almost EUR 3 million − as opposed to an expected breakeven
− based on preliminary results.

The other segments within the Group are unable to fully compensate for this
operating loss. The Group Executive Committee therefore forecasts a 30%
decline in earnings per share to around
EUR 1.25 instead of the previously estimated increase to EUR 2.00, though
this excludes potential positive special effects from the non-operating
business. The definitive results will be published on March 26, 2015.

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com


05.01.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Eckert & Ziegler Strahlen- und Medizintechnik AG
              Robert-Rössle-Str.10
              13125 Berlin
              Germany
Phone:        49 30 941084-138
Fax:          49 30 941084-112
E-mail:       karolin.riehle@ezag.de
Internet:     www.ezag.de
ISIN:         DE0005659700
WKN:          565970
Listed:       Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
              Freiverkehr in Berlin, Düsseldorf, Hamburg, München
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------